Oral News and Research

RSS

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Some of these issues include depression, fatigue, nausea and change of appearance.

11 Jun 2013

Edge Therapeutics announces FDA acceptance of IND application for EG-1962

Edge Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products for acute, fatal or debilitating conditions, announced today that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug application for EG-1962, a novel bio-absorbable nimodipine microparticle formulation.

10 Jun 2013

New Australian research shows evidence for pre-birth programming of food allergies

Among the many new findings presented at the EAACI-WAO World Allergy and Asthma Congress 2013 in Milan from 22-26 June 2013 is new Australian research providing proof for pre-birth programming of food allergies, showing that prenatal environmental factors may already determine predispositions for food allergies rather than only genetic factors.

7 Jun 2013

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an immune system receptor to boost its infectivity and ability to cause disease.

7 Jun 2013

Consumption of cheese and other dairy products may help protect teeth against cavities

Consuming dairy products is vital to maintaining good overall health, and it's especially important to bone health. But there has been little research about how dairy products affect oral health in particular.

6 Jun 2013

Henry Schein Cares expands access to quality oral health care for underserved and at-risk populations

Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, is once again helping expand access to quality oral health care for underserved and at-risk populations through the Calendar of Caring Community Wellness Program.

6 Jun 2013

Viewpoints: Kasich on what would Reagan do about Medicaid; The need for more doctors

Leaders in the states that have decided against expanding (Medicaid) have often invoked Reagan conservatism as the reason to oppose extending Medicaid health care coverage to more people. After all, doesn't (Ronald) Reagan embody modern conservatism? He cut taxes, cut government red tape and fought the growth of entitlements. Yes, he did all those things. However, he also expanded Medicaid, not just once but several times (Ohio Gov. John Kasich, 6/2).

6 Jun 2013

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Days after two landmark resolutions were adopted at the World Health Assembly - on neglected tropical diseases and on research and development, financing and coordination for the health needs of developing countries - over 400 scientists, representatives and ministers of health, ambassadors, national control programme representatives, African regulators, health workers, public health experts, and activists from 21 African countries and 10 others from around the world gather in Nairobi to take stock of health innovation for neglected diseases in Africa over the past decade.

6 Jun 2013

Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

In a major step forward in its plans to deliver healthier, more effective innovations to the fast-growing medical marijuana industry in the U.S., Neutra Corp. announced today that its MMJ subsidiary, Cannabis Technologies, Inc., has formed a new joint venture with Field of View Technologies, LLC, to market and develop breakthrough cannabis delivery systems.

5 Jun 2013

Treatment can restore satisfying sex life post menopause

A satisfying sex life is an important contributor to older adults' quality of life, but the sexual pain that can come after menopause can rob women and their partners of that satisfaction. Treatment can help restore it, shows a global survey including some 1,000 middle-aged North American men and women, published online today in Menopause, the journal of The North American Menopause Society (NAMS).

5 Jun 2013

Study reveals connection between impaired hGH levels, sleep fragmentation

If you've heard that Growth Hormone therapy can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger, you can now add one more ostensible benefit to the list… a good night's sleep!

5 Jun 2013

New Aspen Dental office to open in Beaverton, OR

A new Aspen Dental office is opening in Beaverton, OR on Thursday, June 13. Located at 8660 SW Scholl's Ferry Rd., the practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

5 Jun 2013

Zalicus advancing Z944 into further clinical development

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it is advancing Z944, its novel oral T-type calcium channel blocker, into further clinical development in the third quarter of 2013.

4 Jun 2013

OxThera granted Japanese patents for treating oxalate-related disease

OxThera AB has been granted three Japanese patents during 2012 and 2013. The patents will secure the pharmaceutical composition and the method for treating and preventing oxalate-related disease with micro-organisms and enzymes and will further strengthen the Company's patent estate for this unmet medical need.

4 Jun 2013

Report: 83% of cancer doctors face oncology drug shortages

Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 2013 annual meeting of the American Society of Clinical Oncology (Abstract #CRA6510).

4 Jun 2013

New strategies to prevent ventilator-associated pneumonia in critically ill children

Implementation of a bundle for prevention of ventilator-associated pneumonia in critically ill infants and children may lead to lower rates of VAP in these patients, according to an article in the June issue of Critical Care Nurse.

4 Jun 2013

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

With the arrival of summer, when the sun's ultraviolet rays are strongest, ophthalmologists − medical doctors who specialize in the diagnosis, medical and surgical treatment of eye diseases and conditions − are warning the public that overexposure to these rays can burn the eyes' corneas and cause painful, temporary blindness.

4 Jun 2013

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

The American Academy of Sleep Medicine is advising anyone with Type 2 diabetes or hypertension to be evaluated for sleep apnea by a board-certified sleep medicine physician. The recommendation comes as the group of international clinicians and researchers meets in Baltimore for SLEEP 2013, the foremost gathering of sleep experts annually.

4 Jun 2013

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.

3 Jun 2013

Amgen reports encouraging results from talimogene laherparepvec phase 3 study in patients with metastatic melanoma

Amgen today announced detailed results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).

3 Jun 2013

Oral News and Research

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Edge Therapeutics announces FDA acceptance of IND application for EG-1962

New Australian research shows evidence for pre-birth programming of food allergies

HSV-1 exploits immune system receptor to boost infectivity and cause disease

Consumption of cheese and other dairy products may help protect teeth against cavities

Henry Schein Cares expands access to quality oral health care for underserved and at-risk populations

Viewpoints: Kasich on what would Reagan do about Medicaid; The need for more doctors

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

Treatment can restore satisfying sex life post menopause

Study reveals connection between impaired hGH levels, sleep fragmentation

New Aspen Dental office to open in Beaverton, OR

Zalicus advancing Z944 into further clinical development

OxThera granted Japanese patents for treating oxalate-related disease

Report: 83% of cancer doctors face oncology drug shortages

New strategies to prevent ventilator-associated pneumonia in critically ill children

Ophthalmologists warn that overexposure to sun's UV rays can cause temporary blindness

People with type 2 diabetics, hypertension more likely to have obstructive sleep apnea: Study

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Amgen reports encouraging results from talimogene laherparepvec phase 3 study in patients with metastatic melanoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News